MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Total Expenditure History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Expenditure | ₹6,848 Cr | ₹5,791 Cr | ₹4,565 Cr | ₹4,427 Cr | ₹4,055 Cr |
What is the latest Total Expenditure of MANKIND PHARMA ?
Year | Total Expenditure |
---|---|
Mar2023 | ₹6,848 Cr |
Mar2022 | ₹5,791 Cr |
Mar2021 | ₹4,565 Cr |
Mar2020 | ₹4,427 Cr |
Mar2019 | ₹4,055 Cr |
How is Total Expenditure of MANKIND PHARMA Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2023 | ₹6,848 Cr | 18.24 | |
Mar2022 | ₹5,791 Cr | 26.85 | |
Mar2021 | ₹4,565 Cr | 3.12 | |
Mar2020 | ₹4,427 Cr | 9.18 | |
Mar2019 | ₹4,055 Cr | - |
Compare Total Expenditure of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹90,032.8 Cr | -1.7% | -7.8% | 57.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹370,757.0 Cr | 0.7% | -4.8% | 57.3% | Stock Analytics | |
CIPLA | ₹109,559.0 Cr | 1.9% | -2.4% | 42.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,416.0 Cr | 0.1% | 3% | 12.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,088.9 Cr | 1.3% | 0.5% | 87.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,939.0 Cr | -5.4% | -4.1% | 20% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -1.7% |
-7.8% |
57.2% |
SENSEX | -0.6% |
-2.1% |
18.4% |
You may also like the below Video Courses